[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 4, Issue 3 (Int Biol Biomed J 2018) ::
IBBJ 2018, 4(3): 136-141 Back to browse issues page
Multiple Myeloma Update
Angel Justiz Vaillant *
Department of Para-clinical Sciences, Pathology and Microbiology Unit, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Trinidad and Tobago. , angel.vaillant@sta.uwi.edu
Abstract:   (1474 Views)
This literature review presents the most recent developments in the management of multiple myeloma, which is characterized by the presence of abnormal plasma cells (myeloma cells) that accumulate into the bone marrow. Aspects related to pathophysiology, clinical manifestations, laboratory, study and treatment are described. These pieces of information are necessary to accomplish a better management of the disease, and a reduction in economic burden and incidence of multiple myeloma.
Keywords: Multiple myeloma, immunoglobulin, neoplasm, monoclonal antibody, Bence Jones protein
Full-Text [PDF 397 kb]   (185 Downloads)    
Type of Study: Review | Subject: Cancer
Received: 2018/04/21 | Accepted: 2018/06/26 | Published: 2018/08/4
Add your comments about this article
Your username or Email:


XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Justiz Vaillant A. Multiple Myeloma Update. IBBJ. 2018; 4 (3) :136-141
URL: http://ibbj.org/article-1-177-en.html

Volume 4, Issue 3 (Int Biol Biomed J 2018) Back to browse issues page
International Biological and Biomedical Journal
Persian site map - English site map - Created in 0.05 seconds with 31 queries by YEKTAWEB 3897